Low-dose aspirin does not prevent depression in older adults

Low-dose aspirin does not prevent depression in older adults

(HealthDay)—For older adults, low-dose aspirin does not reduce the risk for depression, according to a study published online June 3 in JAMA Psychiatry.

Michael Berk, M.B.B.Ch., Ph.D., from the Deakin University School of Medicine in Geelong, Australia, and colleagues conducted a to determine the impact of (100 mg) on the risk for depression among healthy . Participants included individuals of all races/ethnicities older than 70 years in Australia and white individuals older than 70 years and black and Hispanic individuals older than 65 years in the United States. A total of 19,114 participants were enrolled: 9,525 and 9,589 received aspirin and placebo, respectively, and were followed for a median of 4.7 years.

The researchers found that the proportion of Center for Epidemiologic Studies Depression 10-item (CES-D-10) scale scores of 8 or higher did not differ significantly at annual visits in the aspirin and placebo groups. The incidence rate of new CES-D-10 scores of 8 or higher was 70.4 and 69.1 events per 1,000 person-years in the aspirin and placebo groups, respectively (hazard ratio, 1.02; 95 percent confidence interval, 0.96 to 1.08; P = 0.54).

"This study failed to confirm any potential benefit of low-dose in reducing the risk of depression in this relatively healthy older population," the authors write.

Several authors disclosed financial ties to the biopharmaceutical and nutrition industries.


Explore further

What are the risks and benefits of low-dose aspirin?

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: JAMA Psychiatry

Copyright © 2020 HealthDay. All rights reserved.

Citation: Low-dose aspirin does not prevent depression in older adults (2020, June 4) retrieved 16 April 2021 from https://medicalxpress.com/news/2020-06-low-dose-aspirin-depression-older-adults.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments